MARKSANS PHARMA
|
MARKSANS PHARMA Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹561 Cr | ₹504 Cr | ₹424 Cr | ₹338 Cr | ₹248 Cr |
| Adjustment | ₹100 Cr | ₹69 Cr | ₹55 Cr | ₹74 Cr | ₹35 Cr |
| Changes In working Capital | ₹-62 Cr | ₹-241 Cr | ₹-126 Cr | ₹-111 Cr | ₹-111 Cr |
| Cash Flow after changes in Working Capital | ₹598 Cr | ₹333 Cr | ₹353 Cr | ₹300 Cr | ₹172 Cr |
| Cash Flow from Operating Activities | ₹458 Cr | ₹207 Cr | ₹230 Cr | ₹237 Cr | ₹99 Cr |
| Cash Flow from Investing Activities | ₹-248 Cr | ₹-49 Cr | ₹-141 Cr | ₹-259 Cr | ₹-84 Cr |
| Cash Flow from Financing Activities | ₹-71 Cr | ₹-65 Cr | ₹-69 Cr | ₹198 Cr | ₹80 Cr |
| Net Cash Inflow / Outflow | ₹139 Cr | ₹93 Cr | ₹21 Cr | ₹176 Cr | ₹94 Cr |
| Opening Cash & Cash Equivalents | ₹496 Cr | ₹403 Cr | ₹382 Cr | ₹206 Cr | ₹112 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | ₹-0.58 Cr | - | - | ₹0.00 Cr | - |
| Closing Cash & Cash Equivalent | ₹634 Cr | ₹496 Cr | ₹403 Cr | ₹382 Cr | ₹206 Cr |
Compare Cashflow Statement of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹15,091.6 Cr | 22.7% | 20.9% | 41.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 22.7% |
20.9% |
41.2% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses